Verily Shutters Medical Device Division, Lays Off Staff — Refocuses on AI & Data

Alphabet’s life-sciences arm Verily has closed its medical-device division and laid off staff as part of a strategic shift to concentrate on precision health, data and AI, according to an internal memo reported by news outlets.

CEO Stephen Gillett highlighted Verily’s contributions — for example, the Dexcom G7 continuous glucose monitor and the Stargazer VNRC screening program — but said the company will now prioritize its core mission in data and AI-driven healthcare.

Key points:

• Verily is discontinuing manufacturing of medical devices and will no longer support those products going forward.
• The exact number of employees affected was not disclosed in the memo.
• The move aligns with Alphabet’s broader shift toward AI and data infrastructure following earlier workforce reductions.

Reporting and sources:

• Engadget: Verily closes medical device division
• Economic Times: Report on layoffs and restructuring

Note: As of publication there was no public Verily or Alphabet press release confirming the memo; the reporting is based on internal communications cited by reputable outlets.

Originally reported by Engadget and Business Insider; summary prepared for publication.